HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thursday Plantation

This article was originally published in The Tan Sheet

Executive Summary

Company requests exemption from OTC labeling final rule for 15% Pure Tea Tree Oil Antiseptic (1/3 fl. oz.). "Label size is too small to fit bar lines and all the wording in the font size required," Australia-based firm states in Oct. 29 letter to FDA. Company's proposed labeling for "Drug Facts" panel excludes bar lines, box. Thursday Plantation still is awaiting agency decision on similar exemption request submitted in March for 2 oz. 100% Pure Tea Tree Oil; firm has submitted several versions of proposed labeling for that product (1"The Tan Sheet" April 30, In Brief)...

You may also be interested in...

Thursday Plantation labeling request

Proposed labeling for Thursday Plantation 100% Pure Tea Tree Oil contains unnecessary information in "Drug Facts" box, FDA advises in Jan. 25 letter. Statement about type of bottle used in packaging "is not required in the 'Other Information' section of the Drug Facts labeling and should be placed elsewhere," agency says. In addition, proposed labeling for 1/3 fl. oz. size uses type size smaller than required 6 point, which "is not acceptable." Thursday Plantation has submitted several labeling exemption requests for its tea tree oil products, asserting package size is too small to fit required bar lines, font size (1"The Tan Sheet" Nov. 26, 2001, In Brief)...

Thursday Plantation

Australia-based tea tree manufacturer requests exemption from OTC labeling final rule for 2 oz. 100% Pure Tea Tree Oil, saying compliance is "impracticable" because "label size is too small to fit bar lines and all the wording in the font size required." Moreover, "should the font size be decreased, the letters bleed slightly, which may cause deterioration of text legibility," company maintains in March 23 letter to FDA. Antiseptic is sold in health food stores worldwide under Thursday Plantation brand

The Growing GLP-1 Therapy Market

Novo Nordisk was not the first biopharmaceutical company to launch a GLP-1 therapy into the market for type 2 diabetes. In fact, Amylin Pharmaceutials’ and Eli Lilly’s Byetta (exenatide) beat Novo’s Victoza (liraglutide) to market by a full five years.  





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts